Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Cortical brain volume abnormalities associated with few or multiple neuropsychiatric symptoms in Alzheimer's disease.

Tascone LDS, Payne ME, MacFall J, Azevedo D, de Castro CC, Steffens DC, Busatto GF, Bottino CMC.

PLoS One. 2017 May 8;12(5):e0177169. doi: 10.1371/journal.pone.0177169. eCollection 2017.

2.

Abnormalities of localized connectivity in schizophrenia patients and their unaffected relatives: a meta-analysis of resting-state functional magnetic resonance imaging studies.

Xiao B, Wang S, Liu J, Meng T, He Y, Luo X.

Neuropsychiatr Dis Treat. 2017 Feb 14;13:467-475. doi: 10.2147/NDT.S126678. eCollection 2017.

3.

Decreased Functional Connectivity of Insular Cortex in Drug Naïve First Episode Schizophrenia: In Relation to Symptom Severity.

Pang L, Kennedy D, Wei Q, Lv L, Gao J, Li H, Quan M, Li X, Yang Y, Fan X, Song X.

PLoS One. 2017 Jan 20;12(1):e0167242. doi: 10.1371/journal.pone.0167242. eCollection 2017.

4.

Longitudinal study of cerebral surface morphology in youth with 22q11.2 deletion syndrome, and association with positive symptoms of psychosis.

Radoeva PD, Bansal R, Antshel KM, Fremont W, Peterson BS, Kates WR.

J Child Psychol Psychiatry. 2017 Mar;58(3):305-314. doi: 10.1111/jcpp.12657. Epub 2016 Oct 27.

PMID:
27786353
5.

Distribution of Response Time, Cortical, and Cardiac Correlates during Emotional Interference in Persons with Subclinical Psychotic Symptoms.

Holper LK, Aleksandrowicz A, Müller M, Ajdacic-Gross V, Haker H, Fallgatter AJ, Hagenmuller F, Kawohl W, Rössler W.

Front Behav Neurosci. 2016 Sep 8;10:172. doi: 10.3389/fnbeh.2016.00172. eCollection 2016.

6.

Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.

Woodberry KA, Shapiro DI, Bryant C, Seidman LJ.

Harv Rev Psychiatry. 2016 Mar-Apr;24(2):87-103. doi: 10.1097/HRP.0000000000000109. Review.

7.

Early Detection of Psychosis: Recent Updates from Clinical High-Risk Research.

Schvarcz A, Bearden CE.

Curr Behav Neurosci Rep. 2015 Jun;2(2):90-101. Epub 2015 Jan 18.

8.

Brain Biomarkers of Vulnerability and Progression to Psychosis.

Cannon TD.

Schizophr Bull. 2016 Jul;42 Suppl 1:S127-32. doi: 10.1093/schbul/sbv173. Epub 2015 Dec 9. Review.

9.

Alterations of lateral temporal cortical gray matter and facial memory as vulnerability indicators for schizophrenia: An MRI study in youth at familial high-risk for schizophrenia.

Brent BK, Rosso IM, Thermenos HW, Holt DJ, Faraone SV, Makris N, Tsuang MT, Seidman LJ.

Schizophr Res. 2016 Jan;170(1):123-9. doi: 10.1016/j.schres.2015.11.013. Epub 2015 Nov 24.

10.

Joint Coupling of Awake EEG Frequency Activity and MRI Gray Matter Volumes in the Psychosis Dimension: A BSNIP Study.

Soh P, Narayanan B, Khadka S, Calhoun VD, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, Pearlson GD.

Front Psychiatry. 2015 Nov 9;6:162. doi: 10.3389/fpsyt.2015.00162. eCollection 2015.

11.

How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis.

Cannon TD.

Trends Cogn Sci. 2015 Dec;19(12):744-56. doi: 10.1016/j.tics.2015.09.009. Epub 2015 Oct 19. Review.

12.

Microglial activation and progressive brain changes in schizophrenia.

Laskaris LE, Di Biase MA, Everall I, Chana G, Christopoulos A, Skafidas E, Cropley VL, Pantelis C.

Br J Pharmacol. 2016 Feb;173(4):666-80. doi: 10.1111/bph.13364. Epub 2016 Jan 8. Review.

13.

Auditory dysfunction in schizophrenia: integrating clinical and basic features.

Javitt DC, Sweet RA.

Nat Rev Neurosci. 2015 Sep;16(9):535-50. doi: 10.1038/nrn4002. Review.

14.

Altered Fronto-Temporal Functional Connectivity in Individuals at Ultra-High-Risk of Developing Psychosis.

Yoon YB, Yun JY, Jung WH, Cho KI, Kim SN, Lee TY, Park HY, Kwon JS.

PLoS One. 2015 Aug 12;10(8):e0135347. doi: 10.1371/journal.pone.0135347. eCollection 2015.

15.

Spontaneous Activity Associated with Delusions of Schizophrenia in the Left Medial Superior Frontal Gyrus: A Resting-State fMRI Study.

Gao B, Wang Y, Liu W, Chen Z, Zhou H, Yang J, Cohen Z, Zhu Y, Zang Y.

PLoS One. 2015 Jul 23;10(7):e0133766. doi: 10.1371/journal.pone.0133766. eCollection 2015.

16.

Hippocampal volume correlates with attenuated negative psychotic symptoms irrespective of antidepressant medication.

Bernasconi R, Smieskova R, Schmidt A, Harrisberger F, Raschle NM, Lenz C, Walter A, Simon A, Riecher-Rössler A, Radue EW, Lang UE, Fusar-Poli P, Borgwardt SJ.

Neuroimage Clin. 2015 Apr 29;8:230-7. doi: 10.1016/j.nicl.2015.04.016. eCollection 2015.

17.

Differences in gray matter volume corresponding to delusion and hallucination in patients with schizophrenia compared with patients who have bipolar disorder.

Song J, Han DH, Kim SM, Hong JS, Min KJ, Cheong JH, Kim BN.

Neuropsychiatr Dis Treat. 2015 May 18;11:1211-9. doi: 10.2147/NDT.S80438. eCollection 2015.

18.

Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders.

Chung Y, Jacobson A, He G, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R, Cannon TD.

Mol Neuropsychiatry. 2015 May 1;1(1):13-22.

19.

Brain imaging during the transition from psychosis prodrome to schizophrenia.

Chung Y, Cannon TD.

J Nerv Ment Dis. 2015 May;203(5):336-41. doi: 10.1097/NMD.0000000000000286. Review.

20.

Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia.

Shelton MA, Newman JT, Gu H, Sampson AR, Fish KN, MacDonald ML, Moyer CE, DiBitetto JV, Dorph-Petersen KA, Penzes P, Lewis DA, Sweet RA.

Biol Psychiatry. 2015 Sep 15;78(6):374-85. doi: 10.1016/j.biopsych.2014.12.029. Epub 2015 Jan 30.

Supplemental Content

Support Center